糖尿病新世界
糖尿病新世界
당뇨병신세계
Diabetes New World
2015年
19期
31-33
,共3页
上呼吸道感染%糖尿病%双黄连颗粒%胰岛素%疗效观察
上呼吸道感染%糖尿病%雙黃連顆粒%胰島素%療效觀察
상호흡도감염%당뇨병%쌍황련과립%이도소%료효관찰
Upper respiratory infection%Diabetes%Shuanghuanglian particles%Insulin%Efficacy
目的:观察双黄连颗粒治疗小儿上呼吸道感染和并糖尿病的效果。方法收集2009—2014年大安市市级医院儿科门诊诊治的80例上呼吸感染合并糖尿病患儿为研究对象,随机分为对照组和研究组各40例,对照组给予常规综合治疗,研究组同时服用双黄连颗粒进行治疗,观察并比较两组患儿的治疗效果。结果对照组患儿中,显效17例,有效16例,无效7例,总有效率为82.50%;研究组患儿中,显效21例,有效17例,无效2例,总有效率为95.00%,两组患儿疗效和总有效率之间的差异有统计学意义(P<0.05),研究组未见与双黄连颗粒有关的不良反应。结论双黄连颗粒在小儿上呼吸道感染治疗中具有重要作用,疗效较为满意,值得临床推广应用。
目的:觀察雙黃連顆粒治療小兒上呼吸道感染和併糖尿病的效果。方法收集2009—2014年大安市市級醫院兒科門診診治的80例上呼吸感染閤併糖尿病患兒為研究對象,隨機分為對照組和研究組各40例,對照組給予常規綜閤治療,研究組同時服用雙黃連顆粒進行治療,觀察併比較兩組患兒的治療效果。結果對照組患兒中,顯效17例,有效16例,無效7例,總有效率為82.50%;研究組患兒中,顯效21例,有效17例,無效2例,總有效率為95.00%,兩組患兒療效和總有效率之間的差異有統計學意義(P<0.05),研究組未見與雙黃連顆粒有關的不良反應。結論雙黃連顆粒在小兒上呼吸道感染治療中具有重要作用,療效較為滿意,值得臨床推廣應用。
목적:관찰쌍황련과립치료소인상호흡도감염화병당뇨병적효과。방법수집2009—2014년대안시시급의원인과문진진치적80례상호흡감염합병당뇨병환인위연구대상,수궤분위대조조화연구조각40례,대조조급여상규종합치료,연구조동시복용쌍황련과립진행치료,관찰병비교량조환인적치료효과。결과대조조환인중,현효17례,유효16례,무효7례,총유효솔위82.50%;연구조환인중,현효21례,유효17례,무효2례,총유효솔위95.00%,량조환인료효화총유효솔지간적차이유통계학의의(P<0.05),연구조미견여쌍황련과립유관적불량반응。결론쌍황련과립재소인상호흡도감염치료중구유중요작용,료효교위만의,치득림상추엄응용。
Objective To investigate the therapeutic effect of Shuanghuanglian particles on respiratory tract infection and diabetes. Methods 80 cases were collected on the diagnosis and treatment of pediatric outpatient respiratory infection asso-ciated with diabetes in children for the study were randomly divided into control and study groups with 40 patients in the control group were given routine treatment, the study group Shuanghuanglian particles while taking treatment, observation and comparison the therapeutic effect of the two groups of children. Results Children in the control group, 17 cases markedly effective in 16 cases, 7 cases, the total effective rate was 82.50%; the children in the study group, 21 cases markedly effective in 17 cases, 2 cases, total effective rate was 95.00 percent, two groups of children efficacy and efficiency of the overall differences were statistically significant between(P<0.05), the study group no adverse reactions associated with Shuanghuanglian particles. Conclusion Shuanghuanglian particles on the treatment of respiratory tract infections play an important role, efficacy is satisfactory, worthy of clinical application.